Autosomal Dominant Polycystic Kidney clinical trials at UCSF
1 in progress, 1 open to new patients
open to eligible people ages 18–60
The goal of the study is to compare and evaluate safety and efficacy of tesevatinib 50mg versus placebo in patients with ADPKD.
San Francisco, California and other locations